The ‘reversibility’ of chronic atrophic gastritis after the eradication of Helicobacter pylori

References

• Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017 Aug;153(2):420–429.
   PubMed Web of Science ®Google Scholar
• Yang H, Hu B. Diagnosis of Helicobacter pylori infection and recent advances. Diagnostics (Basel). 2021 Jul;11(8 1305–1319).
   PubMedGoogle Scholar
• Liou JM, Malfertheiner P, Lee YC, et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020 Dec;69(12):2093–2112.
   PubMed Web of Science ®Google Scholar
• de Vries AC, Meijer GA, Looman CW, et al. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut. 2007 Dec;56(12):1665–1670.
   PubMed Web of Science ®Google Scholar
• Arnold M, Park JY, Camargo MC, et al. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 2020 May;69(5):823–829.
   PubMed Web of Science ®Google Scholar
• Chiang TH, Chang WJ, Chen SL, et al. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. Gut. 2021 Feb;70(2):243–250.
   PubMed Web of Science ®Google Scholar
• Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018 Mar 22;378(12):1085–1095.
   PubMed Web of Science ®Google Scholar
• Choi IJ, Kim CG, Lee JY, et al. Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med. 2020 Jan 30;382(5):427–436.
   PubMed Web of Science ®Google Scholar
• Sousa C, Ferreira R, Azevedo NF, et al. Helicobacter pylori infection: from standard to alternative treatment strategies. Crit Rev Microbiol. 2021;27:1–21.
   Google Scholar
• Sutton P. At last, vaccine-induced protection against Helicobacter pylori. Lancet. 2015 Oct 10;386(10002):1424–1425.
   PubMed Web of Science ®Google Scholar
• Blanchard TG, Czinn SJ. Identification of Helicobacter pylori and the evolution of an efficacious childhood vaccine to protect against gastritis and peptic ulcer disease. Pediatr Res. 2017 Jan;81(1–2):170–176.
   PubMed Web of Science ®Google Scholar
• McCracken KW, Catá EM, Crawford CM, et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature. 2014 Dec 18;516(7531):400–404.
   PubMed Web of Science ®Google Scholar
• Karam SM. Mouse models demonstrating the role of stem/progenitor cells in gastric carcinogenesis. Front Biosci (Landmark Ed). 2010 Jan 1;15:595–603.
   PubMed Web of Science ®Google Scholar
• Hoffmann W. Self-renewal of the gastric epithelium from stem and progenitor cells. Front Biosci (Schol Ed). 2013 Jan 1;5:720–731.
   PubMedGoogle Scholar
• Hoffmann W. Regeneration of the gastric mucosa and its glands from stem cells. Curr Med Chem. 2008;15(29):3133–3144.
   PubMed Web of Science ®Google Scholar
• Han ME, Oh SO. Gastric stem cells and gastric cancer stem cells. Anat Cell Biol. 2013 Mar;46(1):8–18.
   PubMedGoogle Scholar
• Brittan M, Hunt T, Jeffery R, et al. Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut. 2002 Jun;50(6):752–757.
   PubMed Web of Science ®Google Scholar
• Han S, Fink J, Jörg DJ, et al. Defining the identity and dynamics of adult gastric isthmus stem cells. Cell Stem Cell. 2019 Sep 5;25(3):342–356.e7.
   PubMed Web of Science ®Google Scholar
• Nomura S, Esumi H, Job C, et al. Lineage and clonal development of gastric glands. Dev Biol. 1998 Dec 1;204(1):124–135.
   PubMed Web of Science ®Google Scholar
• de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008 Apr;134(4):945–952.
   PubMed Web of Science ®Google Scholar
• Vannella L, Lahner E, Osborn J, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther. 2010 May;31(9):1042–1050.
   PubMed Web of Science ®Google Scholar
• Oberhuber G, Wuendisch T, Rappel S, et al. Significant improvement of atrophy after eradication therapy in atrophic body gastritis. Pathol Res Pract. 1998;194(9):609–613.
   PubMed Web of Science ®Google Scholar
• Yamada T, Miwa H, Fujino T, et al. Improvement of gastric atrophy after Helicobacter pylori eradication therapy. J Clin Gastroenterol. 2003 May-Jun;36(5):405–410.
   PubMed Web of Science ®Google Scholar
• Kang JM, Kim N, Shin CM, et al. Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea. Helicobacter. 2012 Apr;17(2):86–95.
   PubMed Web of Science ®Google Scholar
• Ohkusa T, Fujiki K, Takashimizu I, et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med. 2001 Mar 6;134(5):380–386.
   PubMed Web of Science ®Google Scholar
• Toyokawa T, Suwaki K, Miyake Y, et al. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study. J Gastroenterol Hepatol. 2010 Mar;25(3):544–547.
   PubMed Web of Science ®Google Scholar
• Vannella L, Lahner E, Bordi C, et al. Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up. Dig Liver Dis. 2011 Apr;43(4):295–299.
   PubMedGoogle Scholar
• Annibale B, Di Giulio E, Caruana P, et al. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment Pharmacol Ther. 2002 Oct;16(10):1723–1731.
   PubMed Web of Science ®Google Scholar
• Annibale B, Aprile MR, D’Ambra G, et al. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther. 2000 May;14(5):625–634.
   PubMed Web of Science ®Google Scholar
• Tucci A, Poli L, Tosetti C, et al. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol. 1998 Sep;93(9):1425–1431.
   PubMed Web of Science ®Google Scholar
• Arkkila PE, Seppälä K, Färkkilä MA, et al. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study. Scand J Gastroenterol. 2006 Jul;41(7):782–790.
   PubMed Web of Science ®Google Scholar
• Lu B, Chen MT, Fan YH, et al. Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study. World J Gastroenterol. 2005 Nov 7;11(41):6518–6520.
   PubMed Web of Science ®Google Scholar
• Khan MY, Aslam A, Mihali AB, et al. Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2020 Jun;32(6):686–694.
   PubMed Web of Science ®Google Scholar
• Kong YJ, Yi HG, Dai JC, et al. Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis. World J Gastroenterol. 2014 May 21;20(19):5903–5911.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu L, Shi R, et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion. 2011;83(4):253–260.
   PubMed Web of Science ®Google Scholar
• Suna N, Etik D, Öcal S, et al. The effect of helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a retrospective single center research. Acta Gastroenterol Belg. 2020 Jul-Sep;83(3):381–384.
   PubMed Web of Science ®Google Scholar
• Kodama M, Murakami K, Okimoto T, et al. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol. 2012 Apr;47(4):394–403.
   PubMed Web of Science ®Google Scholar
• Kodama M, Murakami K, Okimoto T, et al. Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation. Digestion. 2012;85(2):126–130.
   PubMed Web of Science ®Google Scholar
• Hwang YJ, Kim N, Lee HS, et al. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years. Aliment Pharmacol Ther. 2018 Feb;47(3):380–390.
   PubMed Web of Science ®Google Scholar
• Hwang YJ, Choi Y, Kim N, et al. The difference of endoscopic and histologic improvements of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication. Dig Dis Sci. 2021 Aug 7. doi:https://doi.org/10.1007/s10620-021-07146-4.
   Web of Science ®Google Scholar
• Ito M, Haruma K, Kamada T, et al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther. 2002 Aug;16(8):1449–1456.
   PubMed Web of Science ®Google Scholar
• Rugge M, Meggio A, Pravadelli C, et al. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut. 2019 Jan;68(1):11–17.
   PubMed Web of Science ®Google Scholar
• Yanaoka K, Oka M, Ohata H, et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer. 2009 Dec 1;125(11):2697–2703.
   PubMed Web of Science ®Google Scholar
• Kato M, Hayashi Y, Nishida T, et al. Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild-to-moderate atrophic gastritis. J Gastroenterol Hepatol. 2021 Aug;36(8):2083–2090.
   PubMed Web of Science ®Google Scholar
• Huh WJ, Khurana SS, Geahlen JH, et al. Tamoxifen induces rapid, reversible atrophy, and metaplasia in mouse stomach. Gastroenterology. 2012 Jan;142(1):21–24.e7.
   PubMed Web of Science ®Google Scholar
• Goldenring JR, Ray GS, Coffey RJ, et al. Reversible drug-induced oxyntic atrophy in rats. Gastroenterology. 2000 Jun;118(6):1080–1093.
   PubMed Web of Science ®Google Scholar
• Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019 Apr;51(4):365–388.
   PubMed Web of Science ®Google Scholar
• Lahner E, Zagari RM, Zullo A, et al. Chronic atrophic gastritis: natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI] Dig Liver Dis . Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2019 Dec;51(12):1621–1632.
   PubMedGoogle Scholar
• Matysiak-Budnik T, Camargo MC, Piazuelo MB, et al. Recent guidelines on the management of patients with gastric atrophy: common points and controversies. Dig Dis Sci. 2020 Jul;65(7):1899–1903.
   PubMed Web of Science ®Google Scholar
• Panella C, Ierardi E, Polimeno L, et al. Proliferative activity of gastric epithelium in progressive stages of Helicobacter pylori infection. Dig Dis Sci. 1996 Jun;41(6):1132–1138.
   PubMed Web of Science ®Google Scholar
• Cahill RJ, Kilgallen C, Beattie S, et al. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut. 1996 Feb;38(2):177–181.
   PubMed Web of Science ®Google Scholar
• Lindén SK, Wickström C, Lindell G, et al. Four modes of adhesion are used during Helicobacter pylori binding to human mucins in the oral and gastric niches. Helicobacter. 2008 Apr;13(2):81–93.
   PubMed Web of Science ®Google Scholar
• Oh JD, Kling-Bäckhed H, Giannakis M, et al. Interactions between gastric epithelial stem cells and Helicobacter pylori in the setting of chronic atrophic gastritis. Curr Opin Microbiol. 2006 Feb;9(1):21–27.
   PubMed Web of Science ®Google Scholar
• Fung C, Tan S, Nakajima M, et al. High-resolution mapping reveals that microniches in the gastric glands control Helicobacter pylori colonization of the stomach. PLoS Biol. 2019 May;17(5):e3000231.
   PubMed Web of Science ®Google Scholar
• Sigal M, Rothenberg ME, Logan CY, et al. Helicobacter pylori activates and expands Lgr5(+) stem cells through direct colonization of the gastric glands. Gastroenterology. 2015 Jun;148(7):1392–404.e21.
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019 Jul 16;51(1):27–41.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309–324.
   PubMed Web of Science ®Google Scholar
• Suganuma M, Watanabe T, Sueoka E, et al. Role of TNF-α-Inducing protein secreted by Helicobacter pylori as a tumor promoter in gastric cancer and emerging preventive strategies. Toxins (Basel). 2021 Mar 1;13(3):181.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Barajon I, Garlanda C. IL-1 and IL-1 regulatory pathways in cancer progression and therapy. Immunol Rev. 2018 Jan;281(1):57–61.
   PubMed Web of Science ®Google Scholar
• Kursunel MA, Esendagli G. The untold story of IFN-γ in cancer biology. Cytokine Growth Factor Rev. 2016 Oct;31:73–81.
   PubMed Web of Science ®Google Scholar
• Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science (New York, NY). 2002 Jan 25;295(5555):683–686.
   Google Scholar
• Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer. 2004 Sep;4(9):688–694.
   PubMed Web of Science ®Google Scholar
• Nagase L, Murata-Kamiya N, Hatakeyama M. Potentiation of Helicobacter pylori CagA protein virulence through homodimerization. J Biol Chem. 2011 Sep 23;286(38):33622–33631.
   PubMed Web of Science ®Google Scholar
• Tohidpour A. CagA-mediated pathogenesis of Helicobacter pylori. Microb Pathog. 2016 Apr;93:44–55.
   PubMed Web of Science ®Google Scholar
• Quiroga AJ, Huertas A, Cómbita AL, et al. Variation in the number of EPIYA-C repeats in CagA protein from Colombian Helicobacter pylori strains and its ability middle to induce hummingbird phenotype in gastric epithelial cells. Biomedica: revista del Instituto Nacional de Salud. 2010 Apr-Jun;30(2):251–258.
   PubMed Web of Science ®Google Scholar
• Batista SA, Rocha GA, Rocha AM, et al. Higher number of Helicobacter pylori CagA EPIYA C phosphorylation sites increases the risk of gastric cancer, but not duodenal ulcer. BMC Microbiol. 2011 Mar 24;11:61.
   PubMed Web of Science ®Google Scholar
• Sicinschi LA, Correa P, Peek RM, et al. CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect. 2010 Apr;16(4):369–378.
   PubMed Web of Science ®Google Scholar
• Higashi H, Tsutsumi R, Fujita A, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14428–14433.
   PubMed Web of Science ®Google Scholar
• Azuma T, Yamazaki S, Yamakawa A, et al. Association between diversity in the Src homology 2 domain–containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis. 2004 Mar 1;189(5):820–827.
   PubMed Web of Science ®Google Scholar
• Li Q, Liu J, Gong Y, et al. Association of CagA EPIYA-D or EPIYA-C phosphorylation sites with peptic ulcer and gastric cancer risks: a meta-analysis. Medicine (Baltimore). 2017 Apr;96(17):e6620.
   PubMed Web of Science ®Google Scholar
• Jones KR, Joo YM, Jang S, et al. Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J Clin Microbiol. 2009 Apr;47(4):959–968.
   PubMed Web of Science ®Google Scholar
• Yong X, Tang B, Li BS, et al. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways. Cell Commun Signal. 2015 Jul 11;13:30.
   PubMed Web of Science ®Google Scholar
• Tabassam FH, Graham DY, Yamaoka Y. Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol. 2009 Jan;11(1):70–82.
   PubMed Web of Science ®Google Scholar
• Yong X, Tang B, Xiao YF, et al. Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer. Cancer Lett. 2016 May 1;374(2):292–303.
   PubMed Web of Science ®Google Scholar
• Wei J, Nagy TA, Vilgelm A, et al. Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterology. 2010 Oct;139(4):1333–1343.
   PubMed Web of Science ®Google Scholar
• Yang H, Wei B, Hu B. Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer. Inflammation Res. 2021 Sep 21;70:1015–1026.
   PubMed Web of Science ®Google Scholar
• Hatakeyama M. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe. 2014 Mar 12;15(3):306–316.
   PubMed Web of Science ®Google Scholar
• Goldenring JR. Pyloric metaplasia, pseudopyloric metaplasia, ulcer-associated cell lineage and spasmolytic polypeptide-expressing metaplasia: reparative lineages in the gastrointestinal mucosa. J Pathol. 2018 Jun;245(2):132–137.
   PubMed Web of Science ®Google Scholar
• Hayakawa Y, Fox JG, Wang TC. Isthmus stem cells are the origins of metaplasia in the gastric corpus. Cell Mol Gastroenterol Hepatol. 2017 Jul;4(1):89–94.
   PubMed Web of Science ®Google Scholar
• Can N, Oz Puyan F, Altaner S, et al. Mucins, trefoil factors and pancreatic duodenal homeobox 1 expression in spasmolytic polypeptide expressing metaplasia and intestinal metaplasia adjacent to gastric carcinomas. Arch Med Sci. 2020;16(6):1402–1410.
   PubMed Web of Science ®Google Scholar
• Huang KK, Ramnarayanan K, Zhu F, et al. Genomic and epigenomic profiling of high-risk intestinal metaplasia reveals molecular determinants of progression to gastric cancer. Cancer Cell. 2018 Jan 8;33(1):137–150.e5.
   PubMed Web of Science ®Google Scholar
• Piazuelo MB, Bravo LE, Mera RM, et al. The Colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions. Gastroenterology. 2021 Mar;160(4):1106–1117.e3.
   PubMed Web of Science ®Google Scholar
• Hayakawa Y, Ariyama H, Stancikova J, et al. Mist1 expressing gastric stem cells maintain the normal and neoplastic gastric epithelium and are supported by a perivascular stem cell niche. Cancer Cell. 2015 Dec 14;28(6):800–814.
   PubMed Web of Science ®Google Scholar
• Amieva M, Peek RM Jr. Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology. 2016 Jan;150(1):64–78.
   PubMed Web of Science ®Google Scholar
• Suarez-Carmona M, Lesage J, Cataldo D, et al. EMT and inflammation: inseparable actors of cancer progression. Mol Oncol. 2017 Jul;11(7):805–823.
   PubMed Web of Science ®Google Scholar
• Markar SR, Wiggins T, Antonowicz S, et al. Assessment of a noninvasive exhaled breath test for the diagnosis of oesophagogastric cancer. JAMA Oncol. 2018 Jul 1;4(7):970–976.
   PubMed Web of Science ®Google Scholar
• Leal A, van Grieken NCT, Palsgrove DN, et al. White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer. Nat Commun. 2020 Jan 27;11(1):525.
   PubMed Web of Science ®Google Scholar
• Shah SC, Piazuelo MB, Kuipers EJ, et al. AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review. Gastroenterology. 2021 Oct;161(4):1325–1332.e7.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li M, Chen S, et al. Endoscopic screening in asian countries is associated with reduced gastric cancer mortality: a meta-analysis and systematic review. Gastroenterology. 2018 Aug;155(2):347–354.e9.
   PubMed Web of Science ®Google Scholar
• Gupta S, Li D, El Serag HB, et al. AGA clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology. 2020 Feb;158(3):693–702.
   PubMed Web of Science ®Google Scholar
• Hu Y, Wan JH, Li XY, et al. Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori. Aliment Pharmacol Ther. 2017 Nov;46(9):773–779.
   PubMed Web of Science ®Google Scholar
• Kumar S, Metz DC, Kaplan DE, et al. Low rates of retesting for eradication of Helicobacter pylori infection after treatment in the veterans health administration. Clin Gastroenterol Hepatol. 2021 Feb;19(2):305–313.e1.
   PubMed Web of Science ®Google Scholar
• Sverdén E, Brusselaers N, Wahlin K, et al. Time latencies of Helicobacter pylori eradication after peptic ulcer and risk of recurrent ulcer, ulcer adverse events, and gastric cancer: a population-based cohort study. Gastrointest Endosc. 2018 Aug;88(2):242–250.e1.
   PubMed Web of Science ®Google Scholar
• Guo CG, Cheung KS, Zhang F, et al. Delay in retreatment of Helicobacter pylori infection increases risk of upper gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2021 Feb;19(2):314–322.e2.
   PubMed Web of Science ®Google Scholar
• Jin G, Lv J, Yang M, et al. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol. 2020 Oct;21(10):1378–1386.
   PubMed Web of Science ®Google Scholar
• Wallace TC, Bailey RL, Blumberg JB, et al. Fruits, vegetables, and health: a comprehensive narrative, umbrella review of the science and recommendations for enhanced public policy to improve intake. Crit Rev Food Sci Nutr. 2020;60(13):2174–2211.
   PubMed Web of Science ®Google Scholar
• Li WQ, Zhang JY, Ma JL, et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. BMJ (Clin Res Ed). 2019 Sep 11;366:l5016.
   PubMed Web of Science ®Google Scholar
• Yang H, Hu B. Immunological perspective: Helicobacter pylori infection and gastritis. Mediators Inflamm. 2022;2022:2944156.
   PubMed Web of Science ®Google Scholar
• Al-Yassir F, Khoder G, Sugathan S, et al. Modulation of stem cell progeny by probiotics during regeneration of gastric mucosal erosions. Biology (Basel). 2021 Jun 28;10(7):596.
   PubMed Web of Science ®Google Scholar
• Park JM, Han YM, Hahm KB. Rejuvenation of Helicobacter pylori-associated atrophic gastritis through concerted actions of placenta-derived mesenchymal stem cells prevented gastric cancer. Front Pharmacol. 2021;12:675443.
   PubMed Web of Science ®Google Scholar
• Park JM, Han YM, Hwang SJ, et al. Therapeutic effects of placenta derived-, umbilical cord derived-, and adipose tissue derived-mesenchymal stem cells in chronic Helicobacter pylori infection: comparison and novel mechanisms. J Clin Biochem Nutr. 2021 Sep;69(2):188–202.
   PubMed Web of Science ®Google Scholar
• Cao Y, Zheng Y, Niu J, et al. Efficacy of Banxia Xiexin decoction for chronic atrophic gastritis: a systematic review and meta-analysis. PloS one. 2020;15(10):e0241202.
   PubMed Web of Science ®Google Scholar
• Dai YK, Zhang YZ, Li DY, et al. The efficacy of Jianpi Yiqi therapy for chronic atrophic gastritis: a systematic review and meta-analysis. PloS one. 2017;12(7):e0181906.
   PubMed Web of Science ®Google Scholar